Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient.

Epstein-Barr virus (EBV) is known to establish latent infections in B-lymphocytes that can cause lymphoproliferative disorders particularly in immunocompromised patients. More recently, the development of rare EBV-associated smooth muscle tumors has been reported in transplant recipients. We herein describe 2 new cases of EBV-associated post-transplant smooth muscle tumors (EBV-PTSMT), including the first in a facial composite tissue graft recipient. Among the striking features shared by these 2 patients were their young ages, the fact that they were naïve for EBV before the transplantation, that they developed a post-transplant lymphoproliferative disorder before the diagnosis of EBV-PTSMT, and that they responded favorably to reduction of immunosuppression. Radiological and histologic features of EBV-PTSMT are shown. Finally, pathophysiology and therapeutic management of EBV-PTSMT are discussed based on a comprehensive review of the literature.
AuthorsA Conrad, A-S Brunet, V Hervieu, C Chauvet, F Buron, S Collardeau-Frachon, C Rivet, P Cassier, S Testelin, A Lachaux, E Morelon, O Thaunat
JournalTransplant infectious disease : an official journal of the Transplantation Society (Transpl Infect Dis) Vol. 15 Issue 5 Pg. E182-6 (Oct 2013) ISSN: 1399-3062 [Electronic] Denmark
PMID24034213 (Publication Type: Case Reports, Journal Article, Review)
Copyright© 2013 John Wiley & Sons A/S.
  • Adult
  • Allografts
  • Epstein-Barr Virus Infections (diagnosis, etiology, therapy, virology)
  • Facial Transplantation (adverse effects)
  • Female
  • Herpesvirus 4, Human (genetics, immunology, isolation & purification)
  • Humans
  • Immunocompromised Host
  • Immunosuppression (adverse effects)
  • Infant
  • Liver Transplantation (adverse effects)
  • Lymphoma, B-Cell (diagnosis, etiology, therapy)
  • Male
  • Postoperative Complications (diagnosis, etiology, therapy)
  • Smooth Muscle Tumor (diagnosis, etiology, therapy, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: